TARA generates human relevant data to enable faster, safer, and more accurate development of new treatments. Our platform can reduce cost and increase the success of important new medicines reaching patients.
Cardiac Drug Discovery
We generate disease models from stem cells, enabling discovery of new medicines for heart conditions.
Our cardiac tissue models reliably represent adult human hearts when applied to drug testing. We can accurately identify cardiovascular complications.
Our platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment.
TARA Biosystems Launches Cardiotype.Ca™ Cardiac Calcium Signaling Assay: In Vitro Assay Accelerates Drug Development in Human-Relevant Heart Models
NEW YORK, NY (Newswire.com) - TARA Biosystems, Inc. launched Cardiotype.Ca™, its in vitro system for assessing cardiac calcium signaling. The new assay …READ MORE
Heart-on-a-Chip Mimics Drug Response Seen in Humans: In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery
NEW YORK, N.Y. (Newswire.com)— Researchers from TARA Biosystems, Inc. and GlaxoSmithKline (GSK) today published data demonstrating that TARA’s engineered heart-on-a-chip system replicated drug responses found in …READ MORE